Dr Akintunde (Tunde) Bello has worked in the field of Pharmaceutical Development for more than 20 years (in the UK and USA) and is currently the Executive Director of Clinical Pharmacology and Pharmacometrics for Oncology and Immuno-Oncology at Bristol-Myers Squibb Co. Tunde leads a team of approximately 20 PhD Scientists working on the development of the next generation of cancer therapies.